SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (372)5/8/2003 9:20:19 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 1840
 
I find the timing of treatments relative to each other (AHSCT vs. anti-CTLA4) sorta weird. I guess that the hope is that conditioning for AHSCT will create conditions for microchimerism? I'd need to see the AHSCT protocol to understand this trial?? Where is it being run? Pittsburgh? Seattle? MGH?

Yes, very aggressive.